Bhalchandra Mirlekar

1.8k total citations · 3 hit papers
15 papers, 973 citations indexed

About

Bhalchandra Mirlekar is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Bhalchandra Mirlekar has authored 15 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 8 papers in Oncology and 1 paper in Infectious Diseases. Recurrent topics in Bhalchandra Mirlekar's work include Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Bhalchandra Mirlekar is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Bhalchandra Mirlekar collaborates with scholars based in United States, India and China. Bhalchandra Mirlekar's co-authors include Yuliya Pylayeva‐Gupta, Daniel Michaud, Benjamin G. Vincent, Sarah Entwistle, Sirui Li, John A. Wrobel, Wei Li, Jenny P.‐Y. Ting, Xianming Tan and Dingka Song and has published in prestigious journals such as Nature, Biochemical and Biophysical Research Communications and Immunological Reviews.

In The Last Decade

Bhalchandra Mirlekar

15 papers receiving 960 citations

Hit Papers

STING-induced regulatory B cells compromise NK function i... 2021 2026 2022 2024 2022 2021 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. STING-induced regulatory B cells compromise NK function in cancer immunity
    2022 213 citations Sirui Li, Bhalchandra Mirlekar et al. Nature profile →
  2. IL-12 Family Cytokines in Cancer and Immunotherapy
    2021 197 citations Bhalchandra Mirlekar, Yuliya Pylayeva‐Gupta Cancers profile →
  3. Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy
    2022 152 citations Bhalchandra Mirlekar SAGE Open Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bhalchandra Mirlekar United States 11 643 458 278 94 60 15 973
Olatz Zenarruzabeitia Spain 18 779 1.2× 406 0.9× 271 1.0× 147 1.6× 53 0.9× 35 1.2k
Álvaro de Mingo Pulido United States 10 736 1.1× 495 1.1× 363 1.3× 74 0.8× 74 1.2× 17 1.1k
H. Mytrang United States 10 454 0.7× 353 0.8× 378 1.4× 190 2.0× 59 1.0× 14 963
Rebecca B. Delconte Australia 13 639 1.0× 327 0.7× 241 0.9× 90 1.0× 31 0.5× 22 887
Luna Minute Spain 12 529 0.8× 504 1.1× 194 0.7× 60 0.6× 39 0.7× 16 858
Luca Rubino Italy 10 827 1.3× 455 1.0× 388 1.4× 169 1.8× 79 1.3× 21 1.3k
Sabina Kaczanowska United States 8 524 0.8× 361 0.8× 319 1.1× 136 1.4× 72 1.2× 11 870
Jun Gui China 15 394 0.6× 281 0.6× 240 0.9× 83 0.9× 65 1.1× 23 784
Daria Briukhovetska Germany 6 366 0.6× 273 0.6× 202 0.7× 60 0.6× 56 0.9× 6 674
Paytsar Topchyan United States 19 513 0.8× 286 0.6× 201 0.7× 95 1.0× 39 0.7× 22 777

Countries citing papers authored by Bhalchandra Mirlekar

Since Specialization
Citations

This map shows the geographic impact of Bhalchandra Mirlekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhalchandra Mirlekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhalchandra Mirlekar more than expected).

Fields of papers citing papers by Bhalchandra Mirlekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhalchandra Mirlekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhalchandra Mirlekar. The network helps show where Bhalchandra Mirlekar may publish in the future.

Co-authorship network of co-authors of Bhalchandra Mirlekar

This figure shows the co-authorship network connecting the top 25 collaborators of Bhalchandra Mirlekar. A scholar is included among the top collaborators of Bhalchandra Mirlekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhalchandra Mirlekar. Bhalchandra Mirlekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Li, Sirui, Bhalchandra Mirlekar, Brandon M. Johnson, et al.. (2022). STING-induced regulatory B cells compromise NK function in cancer immunity. Nature. 610(7931). 373–380. 213 indexed citations breakdown →
2.
Mirlekar, Bhalchandra, Yan Wang, Sirui Li, et al.. (2022). Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity. Cell Reports Medicine. 3(9). 100744–100744. 41 indexed citations
3.
Michaud, Daniel, et al.. (2022). B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer. Frontiers in Immunology. 12. 745873–745873. 17 indexed citations
4.
Mirlekar, Bhalchandra. (2022). Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy. SAGE Open Medicine. 10. 3901919828–3901919828. 152 indexed citations breakdown →
5.
Mirlekar, Bhalchandra, Daniel Michaud, & Yuliya Pylayeva‐Gupta. (2021). IL-35 Detection in B Cells at the mRNA and Protein Level. Methods in molecular biology. 125–147. 2 indexed citations
6.
Mirlekar, Bhalchandra & Yuliya Pylayeva‐Gupta. (2021). IL-12 Family Cytokines in Cancer and Immunotherapy. Cancers. 13(2). 167–167. 197 indexed citations breakdown →
7.
Mirlekar, Bhalchandra, Daniel Michaud, Samuel Lee, et al.. (2020). B cell–Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer. Cancer Immunology Research. 8(3). 292–308. 92 indexed citations
8.
Mirlekar, Bhalchandra. (2020). Co-expression of master transcription factors determines CD4+ T cell plasticity and functions in auto-inflammatory diseases. Immunology Letters. 222. 58–66. 24 indexed citations
9.
Michaud, Daniel, et al.. (2020). Regulatory B cells in cancer. Immunological Reviews. 299(1). 74–92. 138 indexed citations
10.
Michaud, Daniel, Bhalchandra Mirlekar, Steve Bischoff, et al.. (2019). Pancreatic cancer-associated inflammation drives dynamic regulation of p35 and Ebi3. Cytokine. 125. 154817–154817. 10 indexed citations
11.
Mirlekar, Bhalchandra, et al.. (2018). IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer. Cancer Immunology Research. 6(9). 1014–1024. 51 indexed citations
12.
Mirlekar, Bhalchandra, et al.. (2017). Chromatin Remodeling Protein SMAR1 Is a Critical Regulator of T Helper Cell Differentiation and Inflammatory Diseases. Frontiers in Immunology. 8. 72–72. 8 indexed citations
13.
Mirlekar, Bhalchandra, et al.. (2015). MAR binding protein SMAR1 favors IL-10 mediated regulatory T cell function in acute colitis. Biochemical and Biophysical Research Communications. 464(2). 647–653. 8 indexed citations
14.
Mirlekar, Bhalchandra, et al.. (2015). Nuclear matrix protein SMAR1 control regulatory T-cell fate during inflammatory bowel disease (IBD). Mucosal Immunology. 8(6). 1184–1200. 17 indexed citations
15.
Mirlekar, Bhalchandra, et al.. (2013). Mycobacterium tuberculosis: approach to development of improved strategies for disease control through vaccination and immunodiagnosis.. PubMed. 85(2). 65–78. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olatz Zenarruzabeitia Breakdown of academic impact, for papers by Álvaro de Mingo Pulido Breakdown of academic impact, for papers by H. Mytrang Breakdown of academic impact, for papers by Rebecca B. Delconte Breakdown of academic impact, for papers by Luna Minute Breakdown of academic impact, for papers by Luca Rubino Breakdown of academic impact, for papers by Sabina Kaczanowska Breakdown of academic impact, for papers by Jun Gui Breakdown of academic impact, for papers by Daria Briukhovetska Breakdown of academic impact, for papers by Paytsar Topchyan
Rankless by CCL
2026